Physician profile
Kara Rood
NPI 1306170147
$118,548.36
in general payments reported to CMS, 2019-2025
8 companies · $24K in 2025
The $24K reported for 2025 was more than what 99% of Maternal & Fetal Medicine providers received nationally (typical 2025 total: $55.21).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.05 · 2021: $4,086 · 2022: $19K · 2023: $36K · 2024: $36K · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $40K · Honoraria: $36K · Consulting Fee: $14K · Travel and Lodging: $3,990 · Food and Beverage: $1,147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $39,776.95 |
| Honoraria | $36,366.00 |
| Consulting Fee | $14,450.00 |
| Travel and Lodging | $3,989.89 |
| Food and Beverage | $1,147.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $98,160.94 | 2022-2025 | Jada System |
| Gilead Sciences, INC. | $14,716.41 | 2023-2024 | |
| Coopersurgical, INC. | $4,930.00 | 2021-2022 | |
| Alydia Health | $725.96 | 2021 | |
| Indivior INC. | $15.05 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kara Rood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.